Ryaltris nasal spray

Ryaltris is a specialized prescription nasal spray used for the treatment of symptoms associated with allergic rhinitis. It was developed by Glenmark Pharmaceuticals, a major global pharmaceutical company based in India. The product is a fixed-dose combination containing an antihistamine (olopatadine) and a corticosteroid (mometasone furoate).

While Glenmark Pharmaceuticals is the original developer and ultimate owner of the brand, they often partner with local pharmaceutical entities for distribution in various markets. For instance, in several European and international markets, the product is distributed through subsidiaries or local partners. Manufacturing primarily occurs at Glenmark's advanced facilities in India, though the company maintains a global supply chain to reach over 70 countries where the product is approved.